MedPath

Energy expenditure and (assessment of) glucose regulation of participants with diabetes mellitus during and after the Camino: SENSOR-D-4

Completed
Conditions
diabetes
10018424
Registration Number
NL-OMON48461
Lead Sponsor
Isala Klinieken
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
13
Inclusion Criteria

Subjects with type 1 or type 2 diabetes mellitus, using insulin either by MDI
or by CSII
Being fit enough to participate in the Camino walking challenge September 2019.

Exclusion Criteria

Those subjects who participate in the Camino challenge but abstain from
participating in the study. Unable to understand the proposals in Dutch or
Spanish

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath